title: Vasculitis in New Zealand.
abstract: BACKGROUND
  The Asia Pacific Meeting for Vasculitis and ANCA Workshop was held in Tokyo in May 2012. This review of vasculitis in New Zealand (NZ) was prepared for the meeting.
  
  
  METHODS
  A review of significant NZ demographic and health data is presented with information from relevant studies on vasculitis originating from NZ.
  
  
  RESULTS
  Giant cell arteritis occurs in older adults, and has an annual incidence of 12.7/100,000 adults over the age of 50 years in NZ. Kawasaki disease, a rare cause of acquired cardiac disease primarily affecting young children, has an annual incidence of 8.0/100,000 children aged less than 5 years. The prevalence of granulomatosis with polyangiitis varies within NZ, with a 5-year prevalence varying from 29 to 75 cases per million people. Dual anti-glomerular basement membrane disease and ANCA-associated systemic vasculitis is rare, with an annual incidence estimated at 0.47 cases per million people.
  
  
  CONCLUSIONS
  Vasculitis is an uncommon but a significant cause of morbidity and mortality in NZ.
authors.affiliation: Department of Renal Medicine, North Shore Hospital, Waitemata District Health Board, 122 Shakespeare Road, Takapuna, Auckland, 0740, New Zealand. janak.dezoysa@waitematadhb.govt.nz.|Faculty of Medicine and Health Sciences, The University of Auckland, Auckland, New Zealand. janak.dezoysa@waitematadhb.govt.nz.
authors.forename: Janak Rashme
authors.initials: JR
authors.lastname: de Zoysa
mesh_terms: D001323:Autoantibodies / Q000097:blood; D015415:Biomarkers / Q000097:blood; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000453:epidemiology; D009520:New Zealand / Q000453:epidemiology; D011379:Prognosis; D013997:Time Factors; D014657:Vasculitis / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology / Q000401:mortality
chemical_list: D001323:Autoantibodies; D015415:Biomarkers